Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

415 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.
Bossen L, Rebora P, Bernuzzi F, Jepsen P, Gerussi A, Andreone P, Galli A, Terziroli B, Alvaro D, Labbadia G, Aloise C, Baiocchi L, Giannini E, Abenavoli L, Toniutto P, Marra F, Marzioni M, Niro G, Floreani A, Møller HJ, Valsecchi MG, Carbone M, Grønbaek H, Invernizzi P. Bossen L, et al. Among authors: valsecchi mg. Liver Int. 2020 Jun;40(6):1408-1414. doi: 10.1111/liv.14466. Epub 2020 Apr 24. Liver Int. 2020. PMID: 32279422
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study.
Rebora P, Focà E, Salvatori A, Zucchelli A, Ceravolo I, Ornago AM, Finazzi A, Arsuffi S, Bonfanti P, Citerio G, Mazzola P, Ecarnot F, Valsecchi MG, Marengoni A, Bellelli G; FRACoViD Team. Rebora P, et al. Among authors: valsecchi mg. Panminerva Med. 2022 Mar;64(1):24-30. doi: 10.23736/S0031-0808.21.04506-7. Epub 2021 Nov 11. Panminerva Med. 2022. PMID: 34761887
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
Cristoferi L, Porta M, Bernasconi DP, Leonardi F, Gerussi A, Mulinacci G, Palermo A, Gallo C, Scaravaglio M, Stucchi E, Maino C, Ippolito D, D'Amato D, Ferreira C, Nardi A, Banerjee R, Valsecchi MG, Antolini L, Corso R, Sironi S, Fagiuoli S, Invernizzi P, Carbone M. Cristoferi L, et al. Among authors: valsecchi mg. Dig Liver Dis. 2023 Mar;55(3):373-380. doi: 10.1016/j.dld.2022.10.015. Epub 2022 Nov 7. Dig Liver Dis. 2023. PMID: 36357293 Free article.
Development and validation of an electronic database-based frailty index to predict mortality and hospitalization in a population-based study of adults with SARS-CoV-2.
Rebora P, Scirè CA, Occhino G, Bortolan F, Leoni O, Cideni F, Zucchelli A, Focà E, Marengoni A, Bellelli G, Valsecchi MG. Rebora P, et al. Among authors: valsecchi mg. Front Med (Lausanne). 2023 May 12;10:1134377. doi: 10.3389/fmed.2023.1134377. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37250632 Free PMC article.
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort.
Soria A, Fava M, Bernasconi DP, Lapadula G, Colella E, Valsecchi MG, Migliorino GM, D'Ambrosio R, Landonio S, Schiavini M, Spinetti A, Carriero C, Degasperi E, Cologni G, Gatti F, Viganò P, Hasson H, Uberti-Foppa C, Pasulo L, Baiguera C, Rossotti R, Vinci M, Puoti M, Giorgini A, Menzaghi B, Lombardi A, Pan A, Aghemo A, Grossi PA, Boldizzoni R, Colombo S, Viganò M, Rumi MG, Del Poggio P, Valenti L, Giglio O, De Bona A, d'Arminio Monforte A, Colombo A, Spinelli O, Pigozzi MG, Molteni C, Bonfanti P, Terreni N, Perini P, Capretti A, Bella D, Liani C, Polo S, Aimo G, Pagnucco L, Bhoori S, Centenaro R, Graffeo M, Ciaccio A, Dionigi E, Lazzaroni S, Carderi I, Di Marco M, Rizzardini G, Noventa F, Lampertico P, Fagiuoli S. Soria A, et al. Among authors: valsecchi mg. Liver Int. 2020 Apr;40(4):769-777. doi: 10.1111/liv.14386. Epub 2020 Feb 3. Liver Int. 2020. PMID: 31970845
415 results